Shirr Pharmaceuticals Private Limited

Shirr Pharmaceuticals Private Limited - pharma in Thiruvananthapuram, Kerala, India. FY 2026 financials & compliance.
CIN U51397KL2007PTC020592 Incorporated 30 March 2007 ROC Ernakulam HQ Thiruvananthapuram, Kerala, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹3.57 Cr
▲ 2% YoY
Net loss · FY 2025
₹11.34 Lakh
Net margin -3.2%
EBITDA · FY 2025
-₹5.84 Lakh
EBITDA margin -1.6%
Authorised capital
₹9 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹14.82 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
8
Provident fund records

About Shirr Pharmaceuticals Private Limited

Data last updated:

Shirr Pharmaceuticals Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2007PTC020592. Its GSTIN is 32AALCS7176D1Z9 (Kerala).

The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayakrishnan Narayanan Nair (Managing Director) and Asharani Vasanthakumari Sadasivan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 68/428 (1) Near Bank Of India Thiruvallam Branch Thiruvallam P O, Thiruvananthapuram, Kerala, India – 695027.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.57 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹11.34 Lakh (net margin -3.2%) and EBITDA of -₹5.84 Lakh (EBITDA margin -1.6%). Revenue has declined at a compounded annual rate (CAGR) of 1% over five years.

The company has about 8 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹14.82 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397KL2007PTC020592
Registration Number 020592
Incorporation Date 30 March 2007
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Shirr Pharmaceuticals Private Limited's registered office is in Thiruvananthapuram, Kerala. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    68/428 (1) Near Bank Of India Thiruvallam Branch Thiruvallam P O, Thiruvananthapuram, Kerala, India – 695027
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Shirr Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Shirr Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Shirr Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Shirr Pharmaceuticals Private Limited, buy the company report.

Financials of Shirr Pharmaceuticals Private Limited

FY 2025 filings available

Shirr Pharmaceuticals Private Limited reported revenue of ₹3.57 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹3.57 Cr ▲ 2%
Net loss · FY 2025
₹11.34 Lakh margin -3.2%
EBITDA · FY 2025
-₹5.84 Lakh margin -1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 584%
3 years · compounded
▼ 33%
5 years · compounded
▼ 17%

Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 584% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.84 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11.34 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-1.6%
Net Profit Margin-3.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Shirr Pharmaceuticals Private Limited, buy the company report.

Board of directors of Shirr Pharmaceuticals Private Limited

Shirr Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Asharani Vasanthakumari SadasivanDirector27 Jul 200917 Years 3 MonthsCurrent
Jayakrishnan Narayanan NairManaging Director30 Mar 200719 Years 7 MonthsCurrent

Peer comparison

Shirr Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Genext Healthcare Private Limited₹3.57 Cr (FY 2025)-21.0%Guwahati, Assam, India
Shirr Pharmaceuticals Private Limitedthis company₹3.57 Cr (FY 2025)-₹11.34 Lakh-3.2%2.0%8Thiruvananthapuram, Kerala, India
Laxor Pharma Private Limited₹3.57 Cr (FY 2025)-1.0%Ahmedabad, Gujarat, India
Luvis Pharmaceuticals Private Limited₹3.55 Cr (FY 2024)3.0%Raipur, Chhattisgarh, India
Lohitha Chemtek Private Limited₹3.55 Cr (FY 2025)212.0%Hyderabad, Telangana, India

To see the full peer comparison of Shirr Pharmaceuticals Private Limited, buy the company report.

Auditor

Shirr Pharmaceuticals Private Limited is audited by K J THOMAS AND ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
K J THOMAS AND ASSOCIATESFY 2017019454

Shareholding

The shareholding of Shirr Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Shirr Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹14.82 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Mar 2023100725409Others₹14.82 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Shirr Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Shirr Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
8
Active EPFO establishments
1
Employee growth
-27.27%

GST

Shirr Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AALCS7176D1Z9KeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Shirr Pharmaceuticals Private Limited, buy the company report.

Recent activity

Shirr Pharmaceuticals Private Limited has 6 board changes on record since 2007: 2 appointments and 4 cessations. The latest: Jayakrishnan Narayanan Nair ceased to be Managing Director on 29 Nov 2021.

AGM
Shirr Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shirr Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Others amounted to Rs. 14.82 Lakh with Charge ID 100725409 was registered on 22 Mar 2023.
Ceased
Jayakrishnan Narayanan Nair ceased to be Managing Director.
Ceased
Lekha Sreekumar ceased to be Director.
Ceased
Sreekumar Athiyarath ceased to be Director.
Ceased
Asharani Vasanthakumari Sadasivan ceased to be Director.
Appointed
Asharani Vasanthakumari Sadasivan was appointed as Director.
Appointed
Jayakrishnan Narayanan Nair was appointed as Managing Director.
Incorporation
30 Mar 2007
Shirr Pharmaceuticals Private Limited was registered on 30 Mar 2007 with Roc Ernakulam & aged 19 years 7 months as per MCA records.

Frequently asked questions

Shirr Pharmaceuticals is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2007 (19+ years old) and is registered under CIN U51397KL2007PTC020592.

Shirr Pharmaceuticals has 2 current directors:

The latest financial statements of Shirr Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Shirr Pharmaceuticals is 32AALCS7176D1Z9, registered in Kerala.

The CIN (Corporate Identification Number) of Shirr Pharmaceuticals is U51397KL2007PTC020592. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Shirr Pharmaceuticals was incorporated on 30 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ernakulam.

The peers of Shirr Pharmaceuticals by revenue are Genext Healthcare Private Limited, Laxor Pharma Private Limited, Luvis Pharmaceuticals Private Limited, Lohitha Chemtek Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Jayakrishnan Narayanan Nair ceased to be Managing Director on 29 Nov 2021. Lekha Sreekumar ceased to be Director on 31 Mar 2016. Sreekumar Athiyarath ceased to be Director on 31 Mar 2016. Shirr Pharmaceuticals has 6 board changes on record in total.

The registered office of Shirr Pharmaceuticals is at 68428 1 Near Bank Of India Thiruvallam Branch Thiruvallam P O, Thiruvananthapuram, Kerala, India – 695027.

Shirr Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Shirr Pharmaceuticals has open charges of ₹14.82 Lakh and no satisfied charges on record as per latest MCA filings.